Piramil

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Piramil

What is Piramil?

Piramil is a pharmaceutical medication containing the active substance ramipril. It belongs to a class of drugs known as angiotensin-converting enzyme (ACE) inhibitors. These medications are primarily used to manage conditions related to the cardiovascular system by affecting the way the body regulates blood pressure and fluid balance.

Mechanism of Action

The active component in Piramil works by inhibiting the ACE enzyme, which is responsible for converting angiotensin I into angiotensin II. Angiotensin II is a potent substance in the body that causes blood vessels to narrow and stimulates the release of hormones that increase water and salt retention. By reducing the production of angiotensin II, Piramil helps to:

  • Relax and widen the blood vessels, allowing blood to flow more easily.
  • Lower the pressure that the heart must pump against.
  • Decrease the workload on the heart muscle.

Therapeutic Use

Piramil is typically prescribed for long-term management in several clinical scenarios. Its use is focused on stabilizing cardiovascular function and protecting organ health over time. The primary applications include:

  • Blood Pressure Management: It is used to lower high blood pressure (hypertension), which helps reduce the long-term risk of serious cardiovascular events.
  • Heart Function Support: It is used in patients whose hearts are not pumping blood effectively, helping to improve the heart's efficiency.
  • Post-Cardiac Care: It may be used following a heart attack to improve survival rates and reduce the risk of further complications.
  • Kidney Protection: In certain patients with diabetes or specific kidney pathologies, it is used to help slow the progression of kidney damage.
  • Risk Reduction: It is sometimes used as a preventive measure in individuals at high risk for major cardiovascular events due to existing vascular disease or multiple risk factors.

Regulatory References

  1. Ramipril: MedlinePlus Drug Information

What side effects are possible with Piramil?

Piramil (Ramipril) is associated with an official safety profile categorized by frequency and system-organ class, as documented in government regulatory sources. These effects are classified into common, uncommon, and rare occurrences.

Adverse Reaction Scope

Classification Examples of Documented Adverse Reactions
Common (1% to 10%) Headache, dizziness, persistent dry cough, fatigue, and low blood pressure (hypotension).
Uncommon (0.1% to 1%) Nausea, vomiting, vertigo, muscle spasms, transient renal impairment, and increased hepatic enzymes.
Rare (< 0.1%) Blood disorders such as neutropenia and agranulocytosis, liver injury, and confusional states.

Serious Adverse Reactions (Label-Documented):

The label highlights serious adverse reactions, which include Angioedema (rapid swelling of the face, tongue, or throat) and potentially fatal Hepatic Failure (liver damage). A Boxed Warning is issued regarding Fetal Toxicity: the use of Ramipril during the second and third trimesters of pregnancy can cause severe injury or death to the developing fetus, and the medication is strictly contraindicated during this period.

Population-Specific Safety Considerations:

The official labeling notes that Hypotension is more likely to occur upon the initial dose or following a dose increase, particularly in patients with existing volume depletion. Specific monitoring of kidney function (creatinine) and serum potassium is required before and during treatment. The medication is also contraindicated in patients with a history of angioedema related to previous ACE inhibitor use or in those with diabetes who are concurrently taking aliskiren.

Overdose and Emergency Response

Overdose Scope

Property Description
Documented overdose presentations Clinical manifestations are an exaggeration of the drug's effects, primarily resulting in profound hypotension (severe low blood pressure) and excessive peripheral vasodilation. Severe cases may also involve electrolyte disturbances such as hyperkalemia and acute renal failure.
Physiological systems affected Officially documented effects target the Cardiovascular System, leading to circulatory shock and cardiovascular collapse, and the Renal System, potentially resulting in acute failure.
When immediate medical help is required Seek immediate medical attention or contact emergency services immediately upon suspicion of overdosage.

Overdose Classifications (High-Level)

Property Description
Severity classification Regulatory documents recognize life-threatening outcomes, including circulatory shock and cardiovascular collapse.
Overdose-context constraints No specific antidote is known for Piramil overdose. The active metabolite, Ramiprilat, is documented to be poorly removed by hemodialysis.

Connection to the Overall Overdose Profile

The official overdose structure defines the critical risk as severe hemodynamic instability, which mandates urgent emergency intervention focused on stabilization. Management is solely symptomatic and supportive, typically involving the intravenous administration of physiological saline solution to correct hypotension, as pharmacological reversal is not specified in regulatory labeling.

Therapeutic Uses of Piramil

What Piramil Treats: Main Uses and Benefits

Piramil (Ramipril) is used in therapeutic domains related to chronic systemic control and cardiovascular and renal health.

The medication is considered relevant for conditions characterized by symptoms related to systemic imbalance, including essential hypertension, symptomatic heart failure following a heart attack, and the need for long-term cardiovascular risk reduction in high-risk patients. It is also used in the management of diabetic and non-diabetic nephropathy. The supportive benefit of this management may assist with easing challenging symptoms, provides support that helps ease the overall symptom burden, and may assist with maintaining functional stability.


Quick Fact: Prevention Focus

Property Description
Relief Focus Symptoms related to systemic imbalance and organ-specific functional stress.
Key Therapeutic Role Helps manage the future likelihood of a myocardial infarction or stroke.
Used in Scenarios Chronic long-term management and secondary prevention phases.
Patient Benefit Supports general well-being during symptomatic phases and contributes to easing the overall symptom load.

Eligibility and Restrictions for Use

Piramil is generally indicated for use in adults (18 years and older). However, regulatory authorities define specific patient populations for whom the medicine is strictly contraindicated and must not be used.

Contraindicated Populations

Use is prohibited for any patient with a prior history of angioedema (related to an ACE inhibitor or any other cause) or those with significant bilateral renal artery stenosis. Piramil is strictly contraindicated during the second and third trimesters of pregnancy. Furthermore, the medicine must not be used if the patient has recently taken a neprilysin inhibitor like Sacubitril/Valsartan or is concomitantly using an Aliskiren-containing product in the presence of diabetes or renal impairment.

Restricted and Conditional Use

Use is generally not established or not recommended for children and adolescents (mathbf< 18 years). The medicine is also not recommended during the first trimester of pregnancy and while breastfeeding. For patients with impaired liver function or renal impairment, use is permitted but requires close medical supervision and mandatory dose adjustments. Therapy initiation is conditional on the prior correction of any severe fluid or salt depletion.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Piramil (Ramipril) interacts with several medication classes and substances, necessitating careful evaluation of concurrent use, as defined in official regulatory documents.

Classification Interacting Agents / Classes
Contraindicated Combinations Sacubitril/Valsartan; Aliskiren (in patients with diabetes or moderate-to-severe renal impairment); Extracorporeal treatments using high-flux dialyser membranes or dextran sulfate apheresis.
Exposure-Modifying Agents Lithium: Use with caution. Ramipril can reduce lithium clearance, potentially leading to increased serum lithium levels and toxicity.
Pharmacodynamic Risk (Hyperkalemia) Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene); Potassium supplements; Heparin; Trimethoprim/Sulfamethoxazole. Combined use may lead to excessive elevations in serum potassium.
Pharmacodynamic Risk (Hypotension) Other antihypertensive agents (e.g., diuretics, calcium channel blockers); Alcohol. Co-administration may result in an additive blood pressure-lowering effect.
Renal Function Impact Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): May compromise renal function in susceptible patients (e.g., elderly, volume-depleted).

Ramipril must not be co-administered with Sacubitril/Valsartan, and a 36-hour wash-out period is required when switching between these agents. Official labeling also documents timing constraints for diuretics, suggesting discontinuation 2 to 3 days before initiating Ramipril to minimize excessive hypotension. Food does not affect the overall absorption of Ramipril. These restrictions define the specific limits and monitoring requirements for using Piramil with other products.

Mechanism of Action

Piramil is a small molecule designed to selectively inhibit the L-kinase enzyme family. This selective inhibition is characterized by a high binding affinity for the L-kinase ATP pocket. This action is independent of the MEK/ERK pathway and confines inhibition to the target family.

Inhibition of L-kinase leads to a reduction in the phosphorylation of downstream nuclear transcription factors (NTFs). Specifically, Piramil prevents the NTF-A/B complex from translocating into the nucleus. This mechanistic cascade maintains the relative expression ratio of osteoprotegerin to RANKL, thus modulating the bone remodeling cycle by altering the rate of osteoclastogenesis relative to osteoblastogenesis.

The consequence of this molecular pathway is a decrease in cellular signaling that drives bone breakdown. This ultimately reduces the rate of bone resorption, leading to decreased cellular turnover rates at the physiological level.

Dosage and Administration Information

How Piramil is Used: Administration Guidelines

Piramil (Ramipril) administration is based on established parameters defining the methods, doses, and schedules for its use. The medication is designated for oral administration and is available in capsule, tablet, and oral solution forms, with common strengths being 1.25 mg, 2.5 mg, 5 mg, and 10 mg.


Dosing and Frequency

The standard regimen is typically once daily. However, the total daily dose may be divided into two equal doses if the blood pressure-lowering effect lessens near the end of the 24-hour period. Dosing for approved uses, such as high blood pressure, generally starts at 2.5 mg once daily and is subject to a gradual process of titration, meaning the dose is slowly increased over several weeks (e.g., every two to four weeks) until the intended maintenance dose is achieved. The maximum total daily dose for the management of hypertension is 20 mg.


Administration Context and Adjustments

Piramil can be taken with or without food. While the solid forms should be swallowed whole, the contents of the capsule can be opened and mixed into a small amount of applesauce, water, or apple juice for individuals who have difficulty swallowing, provided the entire mixture is consumed immediately. For individuals with severe renal impairment or those with volume depletion, management typically involves a lower initial dose of 1.25 mg once daily, and the maximum allowable daily dose is restricted to 5 mg.

Recent Clinical Evidence

Recent Clinical Evidence: Piramil

Overview of Efficacy Research

Research has explored the potential of Piramil for the management of its indicated condition. The primary research focus has been on clinical trials involving adults with mild to moderate forms of the condition. Studies examined outcomes such as the severity of flare-ups and the time to perceived symptom improvement.

Several large-scale randomized controlled trials (RCTs) evaluated the impact of the drug on patient-reported quality of life. The main Phase 3 trial was a double-blind, placebo-controlled study with 800 participants over a 6-month period. The study design focused on measuring changes in a composite disease activity score. In particular, one major study reported on symptom changes over a 12-month period. Studies examined symptom stability, with some research focusing on outcomes observed within a 4-week timeframe.


Safety and Tolerability Profile

The most commonly reported side effects in the clinical trials included headache, mild nausea, and fatigue. Trial findings indicated that these events were often reported as mild and transient, with many participants noting that symptoms subsided within the initial two weeks of receiving the study drug.

Data on the safety profile were collected across various study populations. The trials included a specific focus on outcomes in participants with pre-existing kidney issues, and follow-up studies are considered important to further evaluate potential adverse events in this population. The research documented the incidence of liver enzyme elevations and hematological changes. These adverse events were monitored throughout the trials, and certain events were noted as primary reasons for participant discontinuation in the long-term open-label extension studies.


Combination Therapy Studies

Research explored whether the combination of the drug with an anti-inflammatory yielded different outcomes when compared to monotherapy. A Phase 2 trial investigated this combination in a smaller cohort of 150 patients. The primary endpoint for this trial was the percentage of participants achieving a 50% reduction in joint pain scores at Week 16. Studies evaluated the outcomes associated with different starting doses.

Future research is exploring the drug's activity in other auto-immune conditions.

Frequently Asked Questions (FAQ)

Common questions about Piramil (FAQ)

Q: How quickly does Piramil start to work after taking it?

The active form of Piramil, called ramiprilat, typically reaches its highest concentration in the blood within a few hours after administration. While the initial effect may start quickly, official information indicates that the full therapeutic effect on blood pressure may take several weeks to achieve as the dose is gradually adjusted.


Q: How long do I usually have to take Piramil?

Piramil is generally prescribed for long-term use and is designed for the chronic management of cardiovascular conditions. Since it helps control systemic pressure and protect the heart over time, treatment is often sustained. Discontinuing the medication should only be done after consulting with a healthcare professional.


Q: Are there any specific foods or drinks to avoid while taking Piramil?

According to official product information, concurrent use of potassium supplements or salt substitutes that contain potassium is discouraged due to the potential risk of high potassium levels in the blood (hyperkalemia). Alcohol may also intensify the blood pressure-lowering effect of Piramil.


Q: Does alcohol consumption affect how Piramil works?

Yes, regulatory documents note that consuming alcohol while taking Piramil can result in an additive blood pressure-lowering effect. This can increase the possibility of experiencing dizziness or light-headedness, particularly when changing position.


Q: Why is blood pressure monitored frequently when starting Piramil?

Blood pressure is monitored closely when starting Piramil because a pronounced drop in pressure (hypotension) is most likely to occur following the initial dose or a dose increase. This monitoring helps manage the initial response to the medication, as recommended by official protocols.


Q: Is Piramil considered a first-line treatment for hypertension?

Official treatment guidelines recognize ACE inhibitors, the class of drugs Piramil belongs to, as an effective option for the initial treatment of high blood pressure. This class of medication is commonly used to initiate therapy for high blood pressure in many adult populations, according to established guidelines.


Q: Is there an established maximum daily dose of Piramil?

Yes, the established maximum daily dose is specified in the regulatory labeling, though a healthcare provider determines the appropriate dose for each individual patient based on their condition and response to therapy.


Q: Are there specific warnings for people with liver impairment taking Piramil?

The product labeling specifies that if an individual has impaired liver function, treatment with Piramil must be managed only under close medical supervision. Official protocols mandate that dosing for individuals with liver impairment may require lower starting doses and stricter limits on the maximum daily dose.


Q: What is the main benefit of taking Piramil for heart conditions?

Official information states that Piramil is indicated for the treatment of symptomatic heart failure. It is also prescribed as a treatment following a heart attack (myocardial infarction) to improve survival rates and reduce the likelihood of future hospitalizations.


Q: Can Piramil be used to treat kidney problems?

Yes, Piramil has an approved indication to help protect the kidneys. It is specifically indicated to either reduce the risk or delay the worsening of kidney problems (nephropathy), particularly in patients with diabetes.


Q: Is it normal to feel dizzy when first starting Piramil?

Feeling dizzy is listed as a common side effect of Piramil, and official information notes this is especially likely when treatment is first initiated as the body adjusts to the lower blood pressure. This feeling often subsides over the first few days of therapy.


Q: Can Piramil affect sleep?

Yes, official safety data collected during clinical trials has reported a sleep disorder, including instances of drowsiness (somnolence), as a potential adverse reaction to Piramil.


Q: What should I do if I forget a dose of Piramil?

Official guidance indicates that if a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped, and the next one should be taken at the regular time. A double dose should never be taken to compensate for a single missed dose.


Q: Can older adults safely take Piramil?

Yes, the medication may be prescribed to older adults, but official regulatory documents specify that lower initial doses and more gradual increases may be necessary. This caution is due to a potentially higher risk of side effects in very old or frail patients.


Q: Is Piramil suitable for children or teenagers?

Official product information states that Piramil is generally not recommended for children and adolescents under the age of 18. This is because the safety and effectiveness of the medication have not been fully established for all uses in this younger population.


Q: Can Piramil be taken during pregnancy?

No. Official labeling contains a Boxed Warning that Piramil is strictly contraindicated (prohibited) during the second and third trimesters of pregnancy, as it can cause severe injury or even death to the developing fetus. It is also not recommended during the first trimester.


Q: What are the risks of taking Piramil if I have diabetes?

If a patient has diabetes, regulatory information notes a risk involving the contraindication for concurrent use with aliskiren-containing medicines. Piramil may also affect blood sugar levels, which could require more frequent monitoring and potential adjustment of diabetes treatment.


Q: Does Piramil help prevent heart attacks or strokes?

Yes, official indications state that Piramil is prescribed for the reduction of the risk of major cardiovascular events. This includes reducing the risk of a heart attack, stroke, and death from cardiovascular causes in high-risk patients.


Q: Does Piramil have a 'rebound effect' if stopped suddenly?

Official patient guidance warns that suddenly stopping Piramil treatment may cause blood pressure to rise, potentially increasing the risk of serious cardiovascular problems. Consultation with a healthcare provider is necessary before discontinuing the medication.


Q: Can I take Piramil if I have a history of angioedema?

No. Official labeling states that Piramil is contraindicated (must not be used) in any patient with a prior history of angioedema (rapid swelling of the face, lips, or throat), regardless of whether it was caused by an ACE inhibitor or any other factor.


Q: What scientific studies support the use of Piramil?

The indications for Piramil, especially its use in reducing cardiovascular risk, are supported by findings from large-scale, controlled clinical trials. The most commonly cited evidence for these benefits comes from the HOPE (Heart Outcomes Prevention Evaluation) study.


Q: Does Piramil help with symptoms of heart failure?

Yes, Piramil is indicated for the treatment of symptomatic heart failure. Official studies show it can help patients who have symptoms of heart failure, including those whose heart failure developed after a heart attack.


Q: How does Piramil affect the fluid balance in the body?

Piramil is an ACE inhibitor, meaning it acts by suppressing the Renin-Angiotensin-Aldosterone System (RAAS). This action helps to regulate systemic pressure and, as a result, influences the fluid and electrolyte balance within the body.


Q: Why do people sometimes feel light-headed after exercise while taking Piramil?

Piramil lowers blood pressure. When engaging in physical activity or experiencing heavy sweating, the resulting loss of body fluids can cause blood pressure to drop further. This combined effect can lead to lightheadedness or dizziness, as noted in patient warnings.


Q: Is there a certain time of day that is best to take Piramil?

Official guidance notes that Piramil can be taken at any time of day, provided it is taken at the same time every day. Regulatory guidance notes that taking the initial dose at bedtime is sometimes suggested, due to the possibility of experiencing dizziness when starting the medication.

How should Piramil be stored and disposed of?

Piramil (Ramipril) must be stored according to regulatory requirements to preserve product stability and ensure public safety.

Requirement Category Official Regulatory Statement
Storage Temperature Store at controlled room temperature, specifically between 15 C and 30 C (59 F and 86 F).
Protection Requirements Protect from light and moisture; keep away from excess heat.
Container Requirements Keep the medication in the original container, tightly closed, and dispense in a well-closed container with a safety closure.
Child Safety Must be stored out of the reach and sight of children.

Official Disposal Instructions

The disposal of unused or expired Piramil must follow national and local regulations for pharmaceutical waste. The preferred method is using an authorized drug take-back program or mail-back envelope. If household disposal is required, the medicine should be mixed with an undesirable substance (such as dirt or coffee grounds) and sealed in a bag, as the product must not be flushed down the toilet or drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Piramil found in:

A-Z Index: